Lactoferrin Stimulates the Mitogen-Activated Protein Kinase in the Human Lymphoblastic T Jurkat Cell Line
Lactoferrin11 (also called lactotransferrin) has been shown to be involved in numerous inflammatory and immune response functions such as regulation of granulocyte monocyte colony stimulating factor6,7,12,17 and of interleukin9 synthesis, activation of NK cell activity13, inhibition of metastasis2 and maturation of T- and B-cells15,16. Recently, it has also been demonstrated the activation of a nuclear reporter gene harbouring the spe-ci fic DNA sequence that lactoferrin recognizes8. Therefore, lactoferrin could be considered as a transcriptional factor1. It requires that lactoferrin is internalized and imported into the nucleus of target cells where it acts as a transcriptional factor1. However, there is no evidence that cell-surface lactoferrin receptors can transport lactoferrin either directly or via a new trafficking pathway to the nucleus. In order to investigate how lactoferrin affects the immune system, we have developed an experimental model using the human lymphoblastic T Jurkat cell line which upon lactoferrin treatment slowly undergoes a maturation process5. Jurkat cells express the lactoferrin receptor10 at the cell surface in coated-pit like domains, associated into clusters, and in different subsets of intracellular vesicles3 . Therefore, we have investigated the first intracellular events following the binding of lactoferrin to lymphocytes: internalization process of lactoferrin and activation of a transduction pathway.
KeywordsJurkat Cell Internalization Process Human Lactoferrin Jurkat Cell Line Lymphoblastic Cell Line
Unable to display preview. Download preview PDF.
- 3.Bi, B.Y., B. Leveugle, J.L. Liu, A. Collard, P. Coppe, A.C. Roche, N. Nillesse, M. Capron, G. Spit, J. Mazurier: (1994) Immunolocalization of the lactoferrin receptor on the human T lymphoblastic cell line Jurkat. Eur. J. Cell Biot 65, 164–171Google Scholar
- 4.Bi, B. Y., J. L. Liu, D. Legrand, A.C. Roche, M. Capron, G. Spik, J. Mazurier: (1996) Internalization of human lactoferrin by Jurkat a human lymphoblastic T-cell line. Eur. J. Cell Biol. 69, 288–296Google Scholar
- 5.Bi, B. Y., A.M. Lefebvre, D. Dus, G. Spik, J. Mazurier: (1997) Effect of lactoferrin on proliferation and differentiation of the Jurkat human lymphoblastic T-cell line. Arch. Immunol. Therap. Exp., 45, 315–320.Google Scholar
- 9.Machnicki, M., M. Zimecki, T. Zagulski: (1993) Lactoferrin regulates the release of tumour necrosis factor alpha and interleukin 6 in vivo. Int. J. Exp. Path. 74, 433–439Google Scholar
- 13.Shau, H., A. Kim, H. Golub: Modulation of natural killer and lymphokine-activated killer cell cytotoxicity by lactoferrin. (1992) J. Leuk. Biol. 51, 343–349Google Scholar
- 14.Willnow, T.E., J.L. Goldstein, K. Orth, M.S. Brown, J. Herz. Low density lipoprotein receptor-related protein and gp330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance. (1992) J. Biol. Chem. 267, 26172–26180PubMedGoogle Scholar
- 15.Zimecki, M., J. Mazurier, M. Machnicki, Z. Wieczorek, J. Montreuil, G. Spik: Immunostimulatory activity of lactotransferrin and maturation of CD47CD8 murine lymphocytes. (1991) Immunol. Lett. 30, 119–124Google Scholar
- 16.Zimecki, M., J. Mazurier, G. Spik, J.A. Kapp: Lactotransferrin induces phenotypic and functional changes in immature B cells. (1995) Immunology 86, 122–127Google Scholar